Description
COA-BACKED BOTANICAL INGREDIENT
Ilex latifolia (normalized from COA pharmacognostic wording) Leaf Extract
Broadleaf Holly Leaf Extract Powder 10:1 is presented for B2B ingredient qualification using representative batch evidence and batch-specific analytical language.
COA-Backed Specification
| Botanical identity | Ilex latifolia (normalized from COA pharmacognostic wording) |
|---|---|
| Plant part | Leaf |
| Form and colour | Fine yellow-brown powder |
| Assay | Extract ratio 10:1; result complies |
| Particle size | 98% through 80 mesh |
| Loss on drying | <=5.0%; result 3.94% |
| Ash | <=5.0%; result 4.01% |
| Representative batch | LXKD190819 |
| Manufacture date | 19 August 2019 |
| Shelf life | Two years when stored properly |
Representative values do not replace the current shipment COA.
Buyer Decision Guide
Compare this Extract ratio 10:1; result complies ratio grade by botanical identity, plant part and physical specification; the ratio is not an active-marker percentage.
- Evaluation sample typically 10-20 g
- Regular MOQ typically 1 kg
- Typical lead time 7-15 working days
How This Grade Differs
Broadleaf Holly Leaf Extract Powder 10:1 is qualified using botanical identity: Ilex latifolia (normalized from COA pharmacognostic wording); plant part: Leaf; offered grade: Extract ratio 10:1; result complies. Its purchasing definition is the stated ratio grade (Extract ratio 10:1; result complies), not a guaranteed active-compound concentration.
When an alternative to Broadleaf Holly Leaf Extract Powder 10:1 is required, compare it against this page’s identity, grade and batch-document requirements.
Browse ingredients related to Broadleaf Holly Leaf Extract Powder 10:1
For a Broadleaf Holly Leaf Extract Powder 10:1 substitution review, match botanical identity, plant part, grade-defining assay or ratio, analytical basis, physical form and offered-lot documentation.
Quality and Documentation
Representative batch LXKD190819 supports the specification table above. Confirm current batch results before release; the representative record remains supporting context rather than a shipment guarantee.
Frequently Asked Questions
What specification defines Broadleaf Holly Leaf Extract Powder 10:1?
For Broadleaf Holly Leaf Extract Powder 10:1: Extract ratio 10:1; result complies.
How can buyers avoid a plant-part substitution?
For Broadleaf Holly Leaf Extract Powder 10:1: Use Ilex latifolia (normalized from COA pharmacognostic wording), Leaf as the identity checkpoint, then confirm that the sample and commercial documents describe the same material.
Does the example batch replace shipment testing?
For Broadleaf Holly Leaf Extract Powder 10:1: The page cites representative batch LXKD190819. Use it as an example of the tested grade, not as the release record for a future shipment.
How is the current COA used in purchasing?
For Broadleaf Holly Leaf Extract Powder 10:1: Request the current COA before issuing approval so the offered lot can be checked against the agreed identity, grade and limits.
What should buyers compare beyond the headline assay?
For Broadleaf Holly Leaf Extract Powder 10:1: Technical acceptance should cover identity, grade-defining data, physical quality and the safety tests required for the intended market.
Do stock and testing affect the lead time?
For Broadleaf Holly Leaf Extract Powder 10:1: The quotation should state the applicable MOQ, pack format and lead time after current inventory and testing needs are reviewed.
How are custom packing requests evaluated?
For Broadleaf Holly Leaf Extract Powder 10:1: Discuss pack format and relevant physical parameters before quotation; feasibility and any MOQ effect are confirmed for the exact request.
Reviews
There are no reviews yet.